The Effect of Gua Sha Therapy on Pain in Parkinson's Disease: a Randomized Controlled Trial
DOI: https://doi.org/10.2147/ijgm.s461958
IF: 2.145
2024-06-15
International Journal of General Medicine
Abstract:Yu Chen Xu, 1, &ast Qiu Qin Wang, 1, &ast Meng Yuan Chen, 1 Yu Jie Gao, 1 Jia Yi Wang, 1 Hao Tian Ge, 1 Heng Weng, 1 Ju Ping Chen, 2 Gui Hua Xu 1 1 School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China; 2 Department of Neurology, Changshu Hospital of Traditional Chinese Medicine, Suzhou, 215500, People's Republic of China &astThese authors contributed equally to this work Correspondence: Gui Hua Xu, School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China, Email Ju Ping Chen, Department of Neurology, Changshu Hospital of Traditional Chinese Medicine, Suzhou, 215500, People's Republic of China, Email Purpose: Pain is a common yet undertreated symptom of Parkinson's disease (PD). This study investigated the effect of Gua Sha therapy on pain in patients with PD. Patients and Methods: A total of 56 PD patients with pain were randomized into either the experimental group (n=28), receiving 12 sessions of Gua Sha therapy, or the control group (n=28) without additional treatment. Participants underwent assessment at baseline, after the twelfth invention, and at the 2-month follow-up timepoints. The primary outcome was KPPS and VAS. Secondary outcomes included UPDRS I–III, PDSS-2, HADS, PDQ-39, and blood biomarkers (5-HT, IL-8, IL-10). Results: The experimental group reported a significant improvement in pain severity, motor functions, affective disorder, and sleep quality ( P < 0.05). Furthermore, increasing trends in both 5-HT and IL-10, as well as decreasing trends in IL-8 were observed. No serious adverse events occurred. Conclusion: The preliminary findings suggest that Gua Sha therapy may be effective and safe for alleviating pain and improving other disease-related symptoms in PD patients. Keywords: Parkinson's disease, pain, Gua Sha therapy, randomized controlled trial Parkinson's disease (PD) is a common, chronic, and progressive neurodegenerative disease. Although the clinical feature of PD is dominated by typical motor symptoms, patients also suffer from various non-motor symptoms (NMS), which often occur throughout PD and have a more significant impact. 1,2 Pain is one of the most frequent and troublesome NMS in PD, affecting approximately 40% to 85% of the patients. 3 Pain is an independent predictor of reduced quality of life. 4 Research has shown that pain is correlated most strongly with sleep disorder, impairing sleep quality and sleep structure, and negatively interacts with depression and cardiovascular disturbance. 5–7 The pathophysiology underlying pain in PD is complex and not fully understood. Research suggests that dysfunctions in the basal ganglia circuit and monoaminergic pathways, 8,9 as well as neural inflammation, may contribute to the pain in PD. 10 These abnormalities can impair descending pain modulation, heightening pain perception and transmission. Additionally, pain in PD can also result from rigidity, akinesia, postural abnormalities, and motor complications. 11 Despite the high prevalence and significant impact, it's a symptom that is under-recognized and inadequately treated. However, there is limited literature to date exploring interventions for pain management in PD. Most interventions, including dopamine agonists, opioids, duloxetine, and non-drug therapies, have demonstrated inadequate relief and require further investigation. 12–14 Therefore, it's necessary to explore more promising interventions to relieve pain in PD and develop additional options for both patients and healthcare professionals. Gua Sha therapy is one of the most commonly used non-pharmaceutical treatments in Chinese traditional medicine, based on the theory of meridians and acupoints. 15 It is an external technique that uses a smooth-edged instrument to press-stroking on treatment areas of the body creating intentionally transient petechiae and ecchymosis. 16 Gua Sha is low-cost and generally well-accepted, with little or no discomfort. These therapeutic petechiae and ecchymosis typically fade within 3–5 days. 17 Gua Sha has long been used clinically for pain relief. 16,18–20 Research suggests that its analgesia effect may result from a cascade of physiological interactions between the nervous system and the immune system. 20,21 Gua Sha can attenuate inflammatory cytokines, increase anti-inflammatory factors, elevate NO levels, and inhibit the neuronal response triggered by the activation of microglial cells, leading to antinociception an -Abstract Truncated-
medicine, general & internal